Author response for "Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial"

Type 1 Diabetes ◽

Controlled Trial ◽

Author Response ◽

Obese Patients ◽

Author response for "Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial"

10.1111/dom.14090/v2/response1 ◽

2020 ◽

Author(s):

Husam Ghanim ◽

Manav Batra ◽

Kelly Green ◽

Sanaa Abuaysheh ◽

Jeanne Hejna ◽

...

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Author Response ◽

Obese Patients ◽

Decision letter for "Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial"

10.1111/dom.14090/v3/decision1 ◽

2020 ◽

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Obese Patients ◽

Review for "Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial"

10.1111/dom.14090/v2/review3 ◽

2020 ◽

Author(s):

Luk Buyse

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Obese Patients ◽

Decision letter for "Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial"

10.1111/dom.14090/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Obese Patients ◽

Review for "Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial"

10.1111/dom.14090/v1/review3 ◽

2020 ◽

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Obese Patients ◽

Review for "Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial"

10.1111/dom.14090/v1/review1 ◽

2020 ◽

Author(s):

Serap Turan

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Obese Patients ◽

OR14-2 Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial

Journal of the Endocrine Society ◽

10.1210/js.2019-or14-2 ◽

2019 ◽

Vol 3 (Supplement_1) ◽

Author(s):

Paresh Dandona ◽

Husam Ghanim ◽

Jeanne Hejna ◽

Kelly Green ◽

Antoine Makdissi ◽

...

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Obese Patients ◽

Author response for "A Pilot Non-Inferiority Randomized Controlled Trial to Assess Automatic Adjustments of Insulin Doses in Adolescents with Type 1 Diabetes on Multiple Daily Injections Therapy"

10.1111/pedi.13052/v2/response1 ◽

2020 ◽

Author(s):

Anas El Fathi ◽

Emilie Palisaitis ◽

Julia E. von Oettingen ◽

Preetha Krishnamoorthy ◽

Robert Kearney ◽

...

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Author Response ◽

Randomized Controlled ◽

Multiple Daily Injections

Review for "Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial"

10.1111/dom.14090/v2/review1 ◽

2020 ◽

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Obese Patients ◽

Review for "Liraglutide Treatment in Overweight and Obese Patients with Type 1 Diabetes: A 26 weeks Randomized Controlled Trial"

10.1111/dom.14090/v1/review2 ◽

2020 ◽

Author(s):

Luk Buyse

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Obese Patients ◽